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Introduction Pathophysiological Processes 
Signs and Symptoms 
 
Significance of Pathophysiology 
     TM is a disease of complex etiology but has symptoms that are 
common to most cases.  Attacks can be mild or severe, with effects 
improving with treatment or permanently disabling the individual.  
Treatment has been targeted to correct potential underlying causes, 
reverse spinal cord inflammation, restore physical function, and 
provide supportive care.  Practitioners should think to include TM into 
the differential diagnoses of cases comprising spontaneous 
development of sensorimotor debility.  
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Underlying Pathophysiology 
     While a rare disease affecting 0.003% of the population (1.34 to 4.6 million people per year), TM deserves special attention 
because of its potential to physically disable an individual (Bhat et al., 2009; Cree, Hess, & West, 2012).   There are multiple etiologies 
that can cause TM; therefore, identifying the diagnosis itself and discovering the causal etiology can be a complex process, postponing 
the treatment process (Brinar et al., 2006; Kitley et al., 2011).   Delaying the diagnoses may potentially contribute to  damaging, lasting 
effects experienced by two-thirds of cases (Cree et al., 2012; Jose Sa, 2009).   Discovering the underlying cause directs treatment 
options, namely, reversing the inflammatory process via steroid injection, plasma exchange in severe cases, and symptomatic 
management that accompanies pharmacotherapy and interdisciplinary practices (Jose Sa, 2009).  
Acute nursing care focuses on thorough patient assessment to 
detect pathophysiological changes in the disease process.  The nurse 
acts to initiate treatment measures, educate the patient, and monitor 
daily testing.  Accurate assessment and monitoring may detect early 
changes in patient status, resulting in a needed change in the 
medical treatment plan (Brinar et al, 2006).  Following initial 
treatment and depending on the intensity of patient symptoms, the 
nurse's role ranges from supportive care to rehabilitative nursing 
with a focus on restoring lost function.  
     Imagine a day like any other, as a healthy performs daily 
tasks without any particular difficulty.  Then, the first fall 
happens.  After standing and recovering, two more falls occur; 
however, despite all physical effort, standing proves to be a 
complete impossibility.  Imagine the fear.  What is going on?   
     This unexplainable scenario happened to an 81 woman 
diagnosed with idiopathic transverse myelitis (TM) in May 
2011, leaving her permanently paralyzed below the 
mysteriously appearing T9 lesion.  This woman had only a 
personal history of asthma and breast cancer, and nothing  
significant in her family history.  After 60 days of lumbar 
punctures, MRI's, CT's, blood tests, plasmapheresis 
treatments, high dose steroids, and IVIG transfusions, the 
neurological damage to her periphery proved to be 
irreversible, leaving her paralyzed below the T9 level.  Still a 
mysterious disease, researchers continue to search for a cause 
and a cure.   
     Raising awareness of TM's prevalence can lead to discovery 
of new treatments.  By researching its etiology and mysterious 
attacks on neurological cells, permanent damage may be 
avoided.   
     A wide array of pathophysiological processes can cause 
the "segmental bilateral acute spinal cord" inflammation 
that results in a TM diagnosis (Bhat, Cheema, Gershwin, & 
Naguwa, 2009).   Prior bacterial or viral infection is present 
in 50% of cases, with other known causes attributed to 
various autoimmune diseases that are idiopathic or caused 
by infections, vaccinations, drug toxicity, spinal cord 
infarction, demyelinating, inflammatory, autoimmune, 
paraneoplastic, bacterial, viral, parasitic, or fungal in origin 
(Bhat et al., 2009; Brinar et al., 2006).  Unfortunately, many 
cases are diagnosed without finding a cause (Jose Sa, 2009).   
     In most cases of TM, the blood brain barrier is broken 
down by the infectious agent, resulting in an inflammatory 
reaction in the CSF and spinal cord with subsequent 
demyelination (Brinar et al., 2006).   Diagnostic criteria 
show an elevated number of cells present in cerebrospinal 
fluid (pleocytosis), elevated protein levels without 
oligoclonal bands, elevated interleukin-6, CF protein level, 
collapsing-response mediator protein 5-IgG, amphiphysin-
IgI, and elevated CSF IgM with later elevated IgG titer or 
antibodies, and the presence of varying autoantibodies 
(Bhat et al, 2009; Kitley, Leite, George, & Palace, 2011). 
SSA/RO antibodies and positive serum aPL are present 
when TM is associated with lupus (Bhat et al., 2009; Jose Sa, 
2009).   In cases considered to be viral in origin, infectious 
agents are not isolated from the nervous system (Bhat et al., 
2009).   Local demyelinating lesions can be small to large, 
partial or complete, symmetrical or asymmetrical, and can 
be found in the spinal cord at varying levels on MRI in 60% 
of patients; conversely, MRI lesions are not found on 40% of 
patients (Brinar et al., 2006; Bhat et al., 2009; Jose Sa, 
2009).   
 
 
Implications for Nursing 
Care 
Conclusion 
Agmon-Levin, N., Kivity, S., Szyper-Kravitz, M., & Shoenfeld, Y. 
(2009).  Transverse myelitis and vaccines: A multi-analysis.  
Lupus, 18(13), 1198-1204.  doi: 10.1177/0961203309345730 
Bhat, A., Naguwa, S., Cheema, G., Gershwin, E. (2010).  The 
epidemiology of transverse myelitis.  Autoimmunity Reviews 
9(12), 395-399.  doi: 10.1016/j.autrev.2009.12.007.  
Borchers, A.T., Gershwin, M.E. (2011).  Transverse myelitis.  
Autoimmunity Reviews 11(3), 231-248.  doi: 
10.1016/j.autrev.2011.05.018.   
Brinar, V.V., Habek, M., Brinar, M., Branko, M., Boban, M. (2006).  
The differential diagnosis of acute transverse myelitis.  Clinical 
Neurology and Neurosurgery, 108(11), 278-283.  
doi:10.1016/j.clineuro.2005.11.008.   
Kitley, J., Leite, M., George, J., & Palace, J. (2012).  The differential 
diagnosis of longitudinally  extensive transverse myelitis.  
Multiple Sclerosis (Houndmills, Basingstoke, England), 18(3), 271-
285.  doi: 10.1177/1352458511406165.   
Pandit, L. (2009).  Transverse myelitis spectrum disorders.  
Neurology India, 57(2), 126-133.  doi: 10.4103/0028-
3886.51278. 
Sa, M.J. (2009).  Acute transverse myelitis: A practical 
reappraisal.  Autoimmunity Reviews 9(2), 128-131.  doi: 
10.1016/j.autrev.2009.04.005 
Sellner, J., Luthi, N., Schupbach, W.M.M., Gebhardt, A., Findling, O., 
Schroth, G., Mattle, H.P., & Nedeltchev., K. (2009).  Diagnostic 
workup of patients with acute transverse myelitis:  Spectrum of 
clinical presentation, neuroimaging and laboratory findings.  
Spinal Cord, 47(4), 312-317.  doi: 10.1038/sc.2008.143.  
West., T.W.,  Hess, C., & Cree, B.A.C. (2012).  Acute transverse 
myelitis:  Demyelinating, inflammatory and infectious 
myelopathies.  Seminars in Neurology, 32(2), 97-113.  doi: 
10.1055/s-0032-1322586. 
     TM attacks may take three weeks to climax in intensity, however, most patients experience their worst deficits within seven days of the 
onset of symptoms.  Up to 44% of patients have reported viral or bacterial infections prior to TM’s classic ascending peripheral 
sensorimotor losses and autonomic dysfunction.  Presentation often includes fever, persistent pain, and parasthesias in the anterior and 
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Diagnostic Imaging: Figure 1 
 
     “Axial topography of 110 spinal cord lesions from 57 
patients with acute transverse myelitis. (a–c) Examples of 
the most frequent axial lesion distributions on T2-
weighted scans are shown (a) lateral, (b) dorsal and (c) 
centromedullary. (d) Schematic presentation of different 
lesions types. (e) Frequencies of different lesion types.” 
Sellner, J., Luthi, N., Schupbach, W.M.M., Gebhardt, A., Findling, 
O., Schroth, G., Mattle, H.P., & Nedeltchev., K. (2009).  Diagnostic 
workup of patients with acute transverse myelitis:  Spectrum of 
clinical presentation, neuroimaging and laboratory findings.  
Spinal Cord, 47(4), 312-317.  doi: 10.1038/sc.2008.143.  
Diagnostic Imaging: Figure 2 
 
     “Multiple foci of acute partial transverse myelitis: 18 years-old 
woman presenting progressive paraparesis and sensory loss in right 
hand. Sagittal spinal cord T1 (A), T2 (B), STIR (C) and T1+Gadolinium 
(D) show multiple T2 cord hyperintensities affecting less than 3 
vertebral bodies with mild and patchy enhancement. Axial T2 images 
at medullary junction (E), C4 (F), D5 (G) and D11 (H) show partial 
involvement of the cord section. Brain MRI study was also performed, 
on axial (I) and parasagittal (J) FLAIR images we can see subcortical 
white hyperintense lesions, consistent with multiple sclerosis.” 
References: Radiology, CDI, Hospital Clinic de Barcelona - 
Barcelona/ES.” 
Ripoll, E., Sarbu, N., Lopez, A., Capurro, S., Oleaga Zufiría, L. (2014).  
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